" Leading Pharma and MedTech players have already understood the value of data. "
In MedTech there are new Industry 4.0 applications evolving. Digital data and increased connectivity are prerequisites for their success along the value chain.
Progress for both patients and physicians
Patients receiving diagnoses from automated tools will actively participate in treatment decisions and share personal data in return. Additive manufacturing technologies like bio printing (the photo shows a kidney structure being printed) have found first applications in the area of regenerative medicine.
The creation of customized prosthetics, implants, and anatomical models are further examples of this development. This means progress for both patients and physicians – and the pharma industry, too.
The digital transformation impacts the healthcare space far beyond the classical physical product. The information dimension will increasingly become part of the future offering either as part of the physical product or in the form of new data-driven business models.
Looking for new revenue streams
Leading Pharma and MedTech players have already understood the value of data and have started to generate extra value for their business in all parts of the value chain, ranging from production & logistics, to marketing & sales.
The most demanding task is to generate new revenue streams for the future and to build a new operating model for areas such as information-guided therapy. In addition, we see new services and players emerging in the 2020 healthcare market: data collectors, connectors and interpreters – e.g. insurers.
Please, explore and share our presentation, which sketches data-driven business models in the healthcare market of 2020.
- Photo Credit: Monty Rakusen / Getty Images
What’s the market pull for E-Health?
Presentation at 9th Berlin Conference on IP in Life Sciences – Digital Health Solution